INTERNET DISSEMINATION OF INVESTIGATIONAL DEVICE DATA ON MANUFACTURER WEB SITES SUPPORTED BY HIMA; WEB LINKS SHOULD BE ENCOURAGED BY FDA, GROUP SAYS
This article was originally published in The Gray Sheet
Executive Summary
Manufacturer dissemination of information on unapproved products and off-label uses of approved products on the Internet should be allowed by FDA, the Health Industry Manufacturers Association says in recent comments to the agency.
You may also be interested in...
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.